Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo y học: "The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now"

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? | Available online http arthritis-research.eom content 10 3 208 Review The need for prognosticators in rheumatoid arthritis. Biological and clinical markers where are we now Josef S Smolen1 2 Daniel Aletaha1 Johannes Grisar1 Kurt Redlich1 Gunter Steiner1 and Oswald Wagner3 1 Division of Rheumatology Department of Internal Medicine III Medical University of Vienna Waehringer Guertel 18-20 A-1090 Vienna Austria 22nd Department of Medicine Hietzing Hospital Wolkersbergenstrasse 1 A-1130 Vienna Austria 3Department of Laboratory Medicine Medical University of Vienna Waehringer Guertel 18-20 A-1090 Vienna Austria Corresponding author Josef S Smolen josef.smolen@meduniwien.ac.at Published 29 May 2008 This article is online at http arthritis-research.com content 10 3 208 2008 BioMed Central Ltd Arthritis Research Therapy 2008 10 208 doi 10.1186 ar2418 Abstract Rheumatoid arthritis is a heterogeneous disease with respect to clinical manifestations serologic abnormalities joint damage and functional impairment. Predicting outcome in a reliable way to allow for strategic therapeutic decision-making as well as for prediction of the response to the various therapeutic modalities available today especially biological agents would provide means for optimization of care. In the present article the current information on biological and clinical markers related to disease activity and joint damage as well as for predictive purposes is reviewed. It will be shown that the relationship of many biomarkers with disease characteristics is confounded by factors unrelated to the disease and that only few biomarkers exist with some predictive value. Moreover clinical markers appear of equal value as biomarkers for this purpose although they likewise have limited capacity in these regards. The analysis suggests the search for better markers to predict outcomes and therapeutic responsiveness in rheumatoid arthritis needs to be intensified. Introduction setting the stage Rheumatoid arthritis RA .

TÀI LIỆU LIÊN QUAN

Báo cáo y học: "Conflict-affected displaced persons need to benefit more from HIV and malaria national strategic plans and Global Fund grants"

Báo cáo y học: "Prolonged N-acetylcysteine therapy in late acetaminophen poisoning associated with acute liver failure – a need to be more cautious"

Báo cáo y học: "Pharmacotherapeutic intervention in impulsive preschool children: The need for a comprehensive therapeutic approach"

Báo cáo y học: "Figuring out what works: a need for more and better studies on the relationship between ICU organization and outcomes"

Báo cáo y học: "Do we need a critical care ultrasound certification program? Implications from an Australian medical-legal perspective"

Báo cáo y học: "Inotropes in goal-directed therapy: Do we need ‘goals’"

Báo cáo y học: " Functional markers to predict the need for prolonged mechanical ventilation in patients with Guillain-Barré syndrome"

Báo cáo y học: "The need for speed"

Báo cáo y học: " Another look at Emergency Department HIV screening in practice: no need to revise expectations"

Báo cáo y học: "The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome"